LORICRIN and psoriasis: We found a strong downregulation of filaggrin expression in the AD and psoriasis models compared to that in the untreated control models (Fig. 3C,D), as well as changes in the expression of loricrin and elafin in the psoriasis and AD models (Fig. S2A-D).